A detailed history of North Crest Asset Manangement, LLC transactions in Novartis Ag stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 57,534 shares of NVS stock, worth $6 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
57,534
Previous 57,153 0.67%
Holding current value
$6 Million
Previous $6.08 Million 8.76%
% of portfolio
0.21%
Previous 0.21%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$106.13 - $120.89 $40,435 - $46,059
381 Added 0.67%
57,534 $6.62 Million
Q2 2024

Jul 16, 2024

SELL
$92.57 - $107.37 $13,237 - $15,353
-143 Reduced 0.25%
57,153 $6.08 Million
Q1 2024

Apr 15, 2024

BUY
$95.27 - $108.47 $286,191 - $325,843
3,004 Added 5.53%
57,296 $5.54 Million
Q4 2023

Jan 30, 2024

BUY
$92.27 - $101.54 $39,122 - $43,052
424 Added 0.79%
54,292 $5.48 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $34,860 - $38,687
-368 Reduced 0.68%
53,868 $5.49 Million
Q2 2023

Jul 21, 2023

SELL
$92.52 - $104.91 $8,974 - $10,176
-97 Reduced 0.18%
54,236 $5.47 Million
Q1 2023

Apr 25, 2023

BUY
$80.03 - $92.81 $3.98 Million - $4.61 Million
49,721 Added 1078.08%
54,333 $5 Million
Q4 2022

Feb 01, 2023

SELL
$75.55 - $92.52 $1.12 Million - $1.37 Million
-14,830 Reduced 76.28%
4,612 $418,000
Q3 2022

Oct 17, 2022

SELL
$74.61 - $87.26 $20,070 - $23,472
-269 Reduced 1.36%
19,442 $1.48 Million
Q2 2022

Jul 18, 2022

BUY
$80.52 - $93.75 $1.59 Million - $1.85 Million
19,711 New
19,711 $1.67 Million
Q1 2022

Apr 18, 2022

SELL
$80.11 - $90.62 $1.71 Million - $1.94 Million
-21,384 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $1.7 Million - $1.88 Million
21,384 New
21,384 $1.87 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.